Show simple item record

dc.contributor.authorCostanza, Mary E.
dc.date2022-08-11T08:11:05.000
dc.date.accessioned2022-08-23T17:33:01Z
dc.date.available2022-08-23T17:33:01Z
dc.date.issued1992-12-02
dc.date.submitted2007-07-30
dc.identifier.citationJ Natl Cancer Inst. 1992 Dec 2;84(23):1833.
dc.identifier.issn0027-8874 (Print)
dc.identifier.pmid1359156
dc.identifier.urihttp://hdl.handle.net/20.500.14038/51078
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1359156&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://jnci.oxfordjournals.org/content/84/23/1833.1.full.pdf
dc.subjectAnthracyclines
dc.subjectAntibiotics, Antineoplastic
dc.subjectBreast Neoplasms
dc.subjectClinical Trials, Phase II
dc.subjectFemale
dc.subjectHumans
dc.subjectPaclitaxel
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.subjectWomen's Studies
dc.titlePhase II studies: untreated breast cancer patients
dc.typeJournal Article
dc.source.journaltitleJournal of the National Cancer Institute
dc.source.volume84
dc.source.issue23
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/wfc_pp/90
dc.identifier.contextkey330326
dc.identifier.submissionpathwfc_pp/90
dc.contributor.departmentDepartment of Medicine, Division of Hematology/Oncology
dc.source.pages1833


This item appears in the following Collection(s)

Show simple item record